PT2129216E - Preparação de uma suspensão viável e armazenável de ovos de helmintas - Google Patents

Preparação de uma suspensão viável e armazenável de ovos de helmintas Download PDF

Info

Publication number
PT2129216E
PT2129216E PT08734901T PT08734901T PT2129216E PT 2129216 E PT2129216 E PT 2129216E PT 08734901 T PT08734901 T PT 08734901T PT 08734901 T PT08734901 T PT 08734901T PT 2129216 E PT2129216 E PT 2129216E
Authority
PT
Portugal
Prior art keywords
suspension
eggs
helminth
vibrant
helmet
Prior art date
Application number
PT08734901T
Other languages
English (en)
Portuguese (pt)
Inventor
Rudolf Wilhelm
Allan Knud Roepstorff
Christian Moliin Outzen Kapel
Original Assignee
Falk Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Falk Pharma Gmbh filed Critical Falk Pharma Gmbh
Publication of PT2129216E publication Critical patent/PT2129216E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00—Preservation of bodies of humans or animals, or parts thereof
    • A01N1/10—Preservation of living parts
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00—Preservation of bodies of humans or animals, or parts thereof
    • A01N1/10—Preservation of living parts
    • A01N1/12—Chemical aspects of preservation
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00—Preservation of bodies of humans or animals, or parts thereof
    • A01N1/10—Preservation of living parts
    • A01N1/12—Chemical aspects of preservation
    • A01N1/122—Preservation or perfusion media
    • A01N1/124—Disinfecting agents, e.g. antimicrobials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/62—Leeches; Worms, e.g. cestodes, tapeworms, nematodes, roundworms, earth worms, ascarids, filarias, hookworms, trichinella or taenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Environmental Sciences (AREA)
  • Dentistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Epidemiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Meat, Egg Or Seafood Products (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
PT08734901T 2007-04-02 2008-03-31 Preparação de uma suspensão viável e armazenável de ovos de helmintas PT2129216E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP07006838A EP1977643A1 (de) 2007-04-02 2007-04-02 Herstellung einer viablen, lagerfähigen Wurmeiersuspension

Publications (1)

Publication Number Publication Date
PT2129216E true PT2129216E (pt) 2011-09-27

Family

ID=38330156

Family Applications (1)

Application Number Title Priority Date Filing Date
PT08734901T PT2129216E (pt) 2007-04-02 2008-03-31 Preparação de uma suspensão viável e armazenável de ovos de helmintas

Country Status (19)

Country Link
US (1) US9017700B2 (enExample)
EP (2) EP1977643A1 (enExample)
JP (1) JP5483731B2 (enExample)
CN (1) CN101646340B (enExample)
AT (1) ATE520304T1 (enExample)
AU (1) AU2008234080B2 (enExample)
CA (1) CA2682525C (enExample)
CY (1) CY1111898T1 (enExample)
DK (1) DK2129216T3 (enExample)
ES (1) ES2368536T3 (enExample)
HR (1) HRP20110715T1 (enExample)
ME (1) ME01257B (enExample)
PL (1) PL2129216T3 (enExample)
PT (1) PT2129216E (enExample)
RS (1) RS51938B (enExample)
RU (1) RU2483740C2 (enExample)
SI (1) SI2129216T1 (enExample)
UA (1) UA96480C2 (enExample)
WO (1) WO2008119534A1 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201402909D0 (en) * 2014-02-19 2014-04-02 Univ Southampton Treating infection
US9603875B1 (en) * 2016-01-07 2017-03-28 NeuOva, LLC Method of making a consumable product with purified embryonated Trichuris suis ova
FR3085687B1 (fr) * 2018-09-07 2021-05-14 Nolivade Composition et procede de conservation
CN109370908A (zh) * 2018-11-16 2019-02-22 中农威特生物科技股份有限公司 一种鸡球虫卵囊的培养和保存液及其应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2059417C1 (ru) * 1992-10-01 1996-05-10 Данилевич Василий Николаевич Способ стерилизации питательных сред
AU740776B2 (en) * 1997-12-31 2001-11-15 University Of Iowa Research Foundation, The Use of parasitic biological agents for prevention and control of autoimmune diseases
DE10163115A1 (de) * 2001-12-24 2003-07-03 Alpha Biocare Gmbh Reinigung und Desinfektion von Eiern von Nematoden und Plathelminthen
US20050118655A1 (en) 2003-11-17 2005-06-02 University Of Iowa Research Foundation Use of parasitic biological agents for diseases prevention and control
PL1968618T3 (pl) * 2005-12-30 2017-10-31 Parasite Tech A/S Kompozycja zawierająca jaja pasożytów oraz sposoby izolowania i przechowywania jaj pasożytów

Also Published As

Publication number Publication date
EP1977643A1 (de) 2008-10-08
JP2010523506A (ja) 2010-07-15
EP2129216A1 (de) 2009-12-09
WO2008119534A1 (de) 2008-10-09
US9017700B2 (en) 2015-04-28
HK1133551A1 (en) 2010-04-01
CN101646340B (zh) 2013-01-02
AU2008234080A1 (en) 2008-10-09
RS51938B (sr) 2012-02-29
CA2682525C (en) 2015-11-17
ES2368536T3 (es) 2011-11-18
DK2129216T3 (da) 2011-10-24
RU2483740C2 (ru) 2013-06-10
US20110008390A1 (en) 2011-01-13
CN101646340A (zh) 2010-02-10
AU2008234080B2 (en) 2013-08-29
UA96480C2 (ru) 2011-11-10
SI2129216T1 (sl) 2011-11-30
ME01257B (me) 2013-06-20
ATE520304T1 (de) 2011-09-15
CY1111898T1 (el) 2015-11-04
RU2009140308A (ru) 2011-05-10
HRP20110715T1 (hr) 2011-11-30
PL2129216T3 (pl) 2011-11-30
JP5483731B2 (ja) 2014-05-07
CA2682525A1 (en) 2008-10-09
EP2129216B1 (de) 2011-08-17

Similar Documents

Publication Publication Date Title
CL2011001769A1 (es) Composición para estimular una respuesta inmune contra la toxina shiga stx2 que comprende polipéptidos que comprenden al menos dos de las tres regiones que definen un epitopo conformacional exclusivo de stx2, los cuales se insertan dentro de una proteína andamio no stx2; dicho polipéptido; ácido nucleico; y método de producción de anticuerpos.
HRP20050532A2 (en) Novel fluoroglycoside heterocyclic derivatives, pharmaceutical products containing said compounds and the use thereof
CL2016002589A1 (es) Uso del compuesto genz-112638 (eliglustat), inhibidor de glucosilceramida sintasa, en el tratamiento de la enfermedad de gaucher y enfermedad de fabry (divisional de solicitud 201201348).
UY31497A1 (es) Nuevos compuestos para el tratamiento de trastornos del snc
BR112012021771A2 (pt) métodos de uso de inibidores de contransportadores de sódio-glicose 1 e 2.
MX2012004311A (es) Derivados de ciclohexano spiro condensados como inhibidores de lipasa sensible a hormonas (hsl) utiles en el tratamiento de diabetes.
BR112012006283A2 (pt) formulação de adamts13 estabilizada, método para fabricar uma formulação de adamts13 estabilizada, kit, e métodos para tratar ou prevenir uma doença e para tratar ou previnir um enfarte
EA201400521A1 (ru) Гетероциклические соединения, лекарственные средства, содержащие указанные соединения, их применение и способы их получения
CO6270217A2 (es) Formulaciones galenicas de alisquireno y valsartan
EA201001288A1 (ru) Лечение гипертонии 25-гидроксивитамином d3
AR093716A1 (es) Composicion de cuidado oral
PE20080338A1 (es) 4-[5-(2-amino-etansulfonil)-isoquinolin-7-il]-fenol como inhibidor de akt (proteina cinasa)
NO20072290L (no) Organiske forbindelser.
EA201990415A1 (ru) Плавучий модуль для модульных платформ солнечных панелей
WO2006102308A3 (en) Beta-lactamyl vasopressin v1b antagonists
DK2129216T3 (da) Fremstilling af en levedygtig, lagringsegnet ormeæg-suspension
CL2008002480A1 (es) Compuestos derivados de 3-(4-aminofenil)-metil-4-hidroxi-5-amino-tiopirano, inhibidores de beta-secretasa bace; procedimiento de preparacion; composicion farmaceutica; combinacion farmaceutica, y su uso en el tratamiento de trastornos neurologicos o vaaculares, tal como la enfermedad de alzheimer, sindrome de down y deterioro de la memoria.
CY1109666T1 (el) Μεθοδος θεραπειας διαταραχων ξηροφθαλμιας και ραγοειδιτιδας
CL2008002060A1 (es) Compuestos derivados de sulfonamida, inhibidores de la produccion de beta amiloide; metodo de preparacion; composicion farmaceutica; kit farmaceutico; y uso en el tratamiento de enfermedades tales como alzheimer, angiopatia amiloide, sindrome de down, entre otras.
WO2007056511A3 (en) Metal-binding therapeutic peptides
UA107177C2 (uk) Імуногенна композиція цвс2 та спосіб приготування такої композиції
EA201000864A1 (ru) Фенилоксетанильные производные
EA201000740A1 (ru) Способ получения 5-(2-этилдигидро-1н-инден-2-ил)-1h-имидазола и его солей
PE20070117A1 (es) Compuestos de n-(2,2-dimetilpropil)-6-{3-fluoro-5-[(3-isoxazolilamino)carbonil]-2-metilfenil}-3-pirimidinacarboxamida y procedimiento de preparacion
WO2016170187A3 (en) Biomarkers for determining the clinical response to cell therapy